-
Shanghai Apeiron Biotechnology patents new PRMT5 degradation inducers
06 Nov 2025 01:10 GMT
-
New antibody-drug conjugates disclosed in Kelun-Biotech patent
30 Oct 2025 20:20 GMT
Immuno-oncology
Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. has divulged antibody-drug conjugates (ADCs) potentially useful for the treatment of cancer. The ADCs comprise an antibody or antigen-binding fragment linked to a cytotoxic drug through a …
-
Beijing Avistone Pharmaceuticals Biotechnology patents new HER2 inhibitors
10 Oct 2025 18:39 GMT
Cancer
Beijing Avistone Pharmaceuticals Biotechnology Co. Ltd. has disclosed spiro/bridged ring compounds acting as HER2 (erbB2) (exon 20 insertion [Ex20Ins] [Ala775_Gly776insTyrValMetAla mutant]) inhibitors reported to be useful for the treatment of …
-
GLP-1R agonists disclosed in Shanghai Yidi Biotechnology patent
15 Sep 2025 22:44 GMT
-
Biotechnology patents: EPO practice and expert exchange
12 Sep 2025 13:50 GMT
… with its member states on biotechnology patents. The event brought together EPO … is facing increasing competition in biotechnology patent filings from the US and …
-
New indazoles disclosed in Nova Biotechnology patent
02 Sep 2025 15:17 GMT
-
[Event] Pharma & Biotech Patent Litigation USA - October 14th - 15th, New York, NY
21 Aug 2025 22:46 GMT
… inaugural Forum on Pharma & Biotech Patent Litigation USA and garner a …
-
Brent Bellows
19 Nov 2025 19:27 GMT
… . He focuses on pharmaceutical and biotechnology patent strategy, including domestic and international …
-
Shenzhen Zhongge Biotechnology patents new PARP-7 inhibitors
30 May 2025 23:02 GMT
Cancer
Shenzhen Zhongge Biotechnology Co. Ltd. has disclosed protein mono-ADP-ribosyltransferase TIPARP (PARP-7; ARTD14) inhibitors reported to be useful for the treatment of inflammatory disorders, immunological disorders, viral infections and cancer.
…
-
Section 101 Roundup: The USPTO, Congress and Realignment
19 Nov 2025 06:45 GMT
… filing and maintaining software and biotech patents could change quickly. Companies should …